The Royal Marsden NHS Foundation Trust in the UK has cured its first patient with an workflow enabled by RayStation’s new adaptive replanning module.
This marks an advancement in the treatment process, potentially saving time for both patients and the hospital.
Go deeper with GlobalData
The Royal Marsden NHS Foundation Trust consultant clinical oncologist Dr Susan Lalondrelle said: “We are extremely proud to be the first cancer centre in the world to treat a patient using RaySearch’s advanced online adaptive radiotherapy technology, and we are hugely grateful to The Royal Marsden Cancer Charity for funding this vital equipment.
“Being able to tailor each treatment session to the patient’s current anatomy, while the patient is on the treatment bed, is a major step forward in delivering more personalised cancer care.”
The treatment was administered using Accuray’s Radixact treatment machine, RayStation, and the current oncology information system of The Royal Marsden.
The effectiveness of the new module in RayStation has been showcased, highlighting the efficiency gains from its use.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataHowever, there is still room for further optimisation in the communication between the systems involved.
The teams at the Royal Marsden and RaySearch are focused on ongoing partnership to streamline the integration and improve system efficiency.
The incorporation of RayCare, oncology information system of RaySearch, is anticipated to further reduce time taken for treatments.
The adaptability of RaySearch software, including RayStation and RayCare, allows for the implementation of an online adaptive workflow with any type of treatment machine.
This capability opens the door for broader adoption of online adaptive radiotherapy.
The first patient treated at The Royal Marsden underwent radical therapy for endometrial cancer using a Radixact linear accelerator.
RaySearch founder and CEO Johan Löf said: “Online adaptive has been a key focus for RaySearch for many years and I am happy that The Royal Marsden has treated its first patient using this groundbreaking RayStation technology.
“RayStation has very advanced tools available for taking online adaptive into clinical practice, and we look forward to collaborating with the team at The Royal Marsden to further improve efficiency in this field, and thereby advance cancer treatment.”
In a separate development, The Royal Marsden unveiled in September 2021 the concrete structure completion for its new treatment and research facility.
The incorporation of RayCare is anticipated to further reduce time taken for treatments.
